Introduction
============

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with \~650,000 new cases and nearly 350,000 patient deaths from HNSCC annually.[@b1-ott-10-2315] Prognosis remains poor, and the 5-year survival rates for HNSCC patients continue to be \<50%. Local tumor recurrence, distant metastasis, and therapeutic resistance appear to be the major contributing factors for this low survival rate.[@b2-ott-10-2315]

Previously identified biomarkers can help in predicting the prognosis of HNSCC. However, their clinical application is limited. Currently, there is no evidence-based recommendation for altering the treatment of patients with HNSCC by the expression of individual biomarkers.[@b3-ott-10-2315] Therefore, it is crucial to investigate the molecular mechanisms involved in proliferation, apoptosis, and invasion of HNSCC and discover more effective biomarkers of HNSCC to improve diagnosis and prevention of the disease.

Currently, genetic and genomics research is developing rapidly, which helps us to understand the potential mechanisms of some diseases.[@b4-ott-10-2315],[@b5-ott-10-2315] For example, microarray analysis is widely used in the field of cancer genetics research, which may measure gene expression on a genome-wide scale simultaneously.[@b6-ott-10-2315]

In the present study, the biological informatics approach was used to analyze the gene expression profiles in HNSCC, and functional analysis was performed to identify differentially expressed genes (DEGs) between HNSCC and normal control. Subsequently, network analysis was applied for the DEGs and a protein--protein interaction (PPI) network was constructed; then, we investigated whether the hub gene of the subnetwork could reduce the overall survival (OS) in TCGA database. Through analyzing their biological functions, pathways, and OS, we may bring to light the underlying mechanisms of HNSCC development and identify the potential candidate biomarkers for diagnosis, prognosis, and drug targets.

Materials and methods
=====================

Microarray data
---------------

Microarray expression profiles of GSE6791[@b7-ott-10-2315] were downloaded from Gene Expression Omnibus database for identifying DEGs of HNSCC. GSE6791, which was already deposited in GPL570 (Affymetrix Human Genome U133 Plus 2.0 Array, Santa Clara, CA, USA), consisted of 42 HNSCC samples and 14 normal epithelial samples.

Data preprocessing and identification of DEGs
---------------------------------------------

The raw array data were subjected to background correction and quartile data normalization. Then, the DEGs between HNSCC samples and normal controls were identified using the empirical Bayes approach in linear models for the microarray data (limma) package.[@b8-ott-10-2315] \|log FC\| \>1 and *P*\<0.05 were selected as the cutoff criterion.

Functional and pathway enrichment analysis of DEGs
--------------------------------------------------

The Database for Annotation, Visualization, and Integrated Discovery (DAVID),[@b9-ott-10-2315] which is a comprehensive set of functional annotation tools, has been used for systematic and integrative analysis of large gene lists. In this work, the significant gene ontology (GO) biological process terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the identified DEGs were performed using DAVID database with the thresholds of *P*\<0.05.

Modules from the PPI network
----------------------------

To evaluate the interactive relationships among DEGs, the DEGs were mapped to the Search Tool for the Retrieval of Interacting Genes(STRING) database.[@b10-ott-10-2315] Then, the interaction relationships of DEGs were selected to construct the PPI network (combined score \>0.8) and visualized using Cytoscape.[@b11-ott-10-2315] The Molecular Complex Detection (MCODE) plugin[@b12-ott-10-2315] in Cytoscape was used to screen the modules of PPI network, using cutoff values as follows: MCODE scores \>15 and number of nodes \>15. Moreover, the function and pathway enrichment analysis of DEGs in each module was performed using DAVID.

Survival analysis of the hub gene
---------------------------------

OS analysis was performed using HNSCC samples from the TCGA dataset and mRNA *Z*-score data files were downloaded from the cBioPortal.[@b13-ott-10-2315] Patients were classified into high or low expression based on whether *Z*-score expression was \> median (high) or \< median (low). Based on these categories, log-rank analysis and Kaplan--Meier plots were produced using Prism Software (GraphPad Software, Inc., La Jolla, CA, USA).

Results
=======

Identification of DEGs
----------------------

The total number of samples analyzed was 42 HNSCC samples, along with 14 normal epithelial samples. After data preprocessing, DEG analysis was performed using the limma software package. A total of 811 genes were identified after the analyses of GSE6791, including 550 upregulated and 261 downregulated genes.

GO and KEGG pathway enrichment analyses
---------------------------------------

We uploaded all 811 DEGs to the online software DAVID to identify overrepresented GO categories and KEGG pathways. GO analysis results showed that the most overrepresented GO terms in biological processes were enriched in extracellular matrix (ECM) organization, antigen processing and presentation of exogenous peptide antigen via major histocompatibility class I, transporter associated with antigen processing-dependent, and collagen catabolic process. In addition, the most enriched GO terms in molecular function and cellular component were threonine-type endopeptidase activity and extracellular exosome, respectively. On the other hand, the most enriched KEGG pathway terms were as follows: ECM--receptor interaction, amebiasis, proteasome, focal adhesion, and small cell lung cancer ([Table 1](#t1-ott-10-2315){ref-type="table"}).

Coexpression network analysis of DEGs
-------------------------------------

To interpret the biological meaning of the identified DEGs, we constructed a coexpression network for the DEGs with a combined score \>0.8 and with significant interaction relation composed of 401 nodes and 1,254 edges by STRING database analysis ([Figure 1](#f1-ott-10-2315){ref-type="fig"}). From the coexpression network of the selected DEGs, the top 15 hub genes were determined according to the number of the interacting edges: *CDK1*, *PTK2*, *ITGAV*, *APP*, *COL1A1*, *MMP9*, *AURKA*, *BMP2*, *ITGB4*, *CDC20*, *SDC4*, *COL1A2*, *ITGA6*, *PSMA7*, and *STAT1* ([Table 2](#t2-ott-10-2315){ref-type="table"}). The distinct modules of 401 DEGs and their interacting genes were further identified by the MCODE using Cytoscape software. Among the modules, two subnetworks with \>15 nodes were selected ([Figure 2](#f2-ott-10-2315){ref-type="fig"}), and enrichment analysis showed that the genes in the subnetworks were mainly associated with proteasome, ECM--receptor interaction, protein digestion and absorption, and focal adhesion ([Table 3](#t3-ott-10-2315){ref-type="table"}).

Hub genes were validated as an independent predictor for OS in the TCGA cohort
------------------------------------------------------------------------------

We subsequently sought to assess the significance of expression of 15 hub genes in HNSCC. Therefore, the relation between expression of 15 hub genes and OS in the TCGA HNSCC cohort (461 patients) was verified, and the patients were divided into low or high expression groups according to the median expression. Our results showed that poor OS was associated only in those patients with high expression of *PSMA7* (HR: 1.60 \[1.20--2.10\], *P*=0.0009) in the TCGA HNSCC cohort, as well as *ITGA6* (HR: 1.32 \[1.00--1.75\], *P*=0.0472), *ITGB4* (HR: 1.38 \[1.05--1.83\], *P*=0.0113), and *APP* (HR: 1.40 \[1.04--1.87\], *P*=0.0113; [Figure 3](#f3-ott-10-2315){ref-type="fig"}).

Conclusion
==========

Despite advances in surgical, chemotherapy, and medical therapy, the overall mortality of HNSCC has remained virtually unchanged over the past decades. The lethality of HNSCC is mainly due to difficulties in detecting it at an early stage and the lack of effective treatments for patients in advanced stages. Interestingly, bioinformatics plays a major role in the analysis and interpretation of genomic and proteomic data.[@b14-ott-10-2315] For example, some researchers focus on bioinformatics, nanogenomics, and nanoproteomics aspects of contemporary nanodentistry and summarize some proteomics and proteogenomics approaches for oral diseases.[@b15-ott-10-2315],[@b16-ott-10-2315] Therefore, in the present study, we attempted to utilize comprehensive bioinformatics methods to explore the potential molecular mechanism of HNSCC to improve survival rate and prevention.

In this study, a total of 811 DEGs were screened, consisting of 550 upregulated genes and 261 downregulated genes. Moreover, we selected two significant modules with several key DEGs (like *PSMA7*, *ITGA6*, and *ITGB4*) in HNSCC regulatory network, and functional enrichment analyses showed that these key DEGs were mainly enriched in ECM--receptor interaction, which is closely related to cancer. Finally, survival analysis of these hub genes revealed that four overexpressed genes were significantly correlated with poor OS of patients in the TCGA HNSCC cohort, and these included *PSMA7*, *ITGA6*, *ITGB4*, and *APP*.

The data showed that *PSMA7* is involved in "module 1" of the gene coexpression network, which is enriched in the proteasome pathway. Many studies have suggested that proteasome promotes the degradation of oxidatively damaged proteins that play a role in the cell cycle and transcription, which are essential for cancer improvement. Previously, it was reported that *PSMA7* inhibits the proliferation, tumorigenicity, and invasion of human lung adenocarcinoma cells.[@b17-ott-10-2315] Similar results also showed that high expression of *PSMA7* is associated with liver metastasis in colorectal cancer.[@b18-ott-10-2315] Besides, Hu et al also found depletion of *PSMA7* inhibited cell growth, invasion, and migration in RKO cells and strongly suppressed the tumorigenic ability of RKO cells in vivo.[@b19-ott-10-2315] Taken together, we speculate that the overexpression of *PSMA7* may contribute to HNSCC progression and correlate with a poor prognosis.

On the other hand, *ITGA6* and *ITGB4*, which are found in "module 2" in PPI network, were associated with the ECM--receptor interaction pathway, and belong to the integrin family, which participates in cell adhesion as well as cell surface-mediated signaling. Interactions between cells and the ECM could lead to the direct or indirect control of cellular processes of adhesion, migration, differentiation, proliferation, and apoptosis.[@b20-ott-10-2315] As previously reported, silencing of *ITGA6* genes significantly inhibited cell migration and invasion in head and neck cancer cells and hepatocellular carcinoma cells.[@b21-ott-10-2315],[@b22-ott-10-2315] Similarly high *ITGA6* expression was shown to enhance invasion in models of metastatic breast cancer.[@b23-ott-10-2315] Moreover, Kwon et al[@b24-ott-10-2315] found *ITGA6* is a possible target for antibody-related diagnostic and therapeutic modalities in esophageal squamous cell carcinoma. Meanwhile, *ITGB4* regulates migration and invasion in models of metastatic prostate cancer.[@b25-ott-10-2315] Moreover, Masugi et al[@b26-ott-10-2315] found that knockdown of *ITGB4* reduced the migration and invasion and that upregulation of *ITGB4* promoted cell scattering and motility in pancreatic ductal adenocarcinoma cells. Besides, our study shows that *ITGB4* was associated with poor prognosis in HNSCC; similar results have also been shown in pancreatic ductal adenocarcinoma patients.[@b27-ott-10-2315] Together, we speculate that *ITGA6* and *ITGB4* in ECM--receptor interaction signaling pathway may play a significant role in HNSCC.

Amyloid-β precursor protein (*APP*) is the highly conservative single transmembrane protein with a receptor-like structure that has been shown to be involved in Alzheimer disease,[@b28-ott-10-2315] but its function in normal physiological is unclear. Interestingly, *APP* is increased in many different cancers, such as colon cancer, pancreatic cancer, and thyroid cancer.[@b29-ott-10-2315]--[@b31-ott-10-2315] Lim et al[@b32-ott-10-2315] found that overexpression of *APP* is found both in malignant breast cancer cell lines and in human breast cancer tissues, and *APP* could regulate cell growth, apoptosis, and motility of breast cancer, possibly via engagement of AKT-mediated signaling pathways. Similarly, *APP* could promote cell growth in pancreatic cancer cells.[@b31-ott-10-2315] In addition, Ko et al[@b33-ott-10-2315] found a significant increase of *APP* in an oral squamous cell carcinoma (OSCC) tissue and also that OSCC patients with high mRNA levels of *APP* had poor prognoses. The abovementioned studies show that *APP* may be involved in the pathogenesis of malignant tumors by affecting cell growth or apoptosis, thereby supporting our findings.

In summary, the current study was intended to identify DEGs with comprehensive bioinformatics analysis to find the potential biomarkers and predict progression of diseases. We found that hub genes of complex networks, such as *PSMA7*, *ITGA6*, *ITGB4*, and *APP*, may be exploited as a prognostic tool for HNSCC. Finally, our results suggested that proteasome and ECM--receptor interaction may be important in the development of HNSCC. However, further experimental studies are still required to prove our findings and determine the potential clinical value of these as biomarkers.
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![PPI network of differentially expressed genes.\
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![Functional modules in the PPI network.\
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###### 

Functional and pathway enrichment analysis of upregulated and downregulated DEGs in HNSCC

  ID               Go term                                                                                           Count   *P*-value
  ---------------- ------------------------------------------------------------------------------------------------- ------- -----------
  GO_function                                                                                                                
   GO_BP:0030198   ECM organization                                                                                  43      2.07E--18
   GO_BP:0002479   Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent   23      5.77E--15
   GO_BP:0030574   Collagen catabolic process                                                                        21      1.10E--12
   GO_BP:0060337   Type I interferon signaling pathway                                                               20      1.13E--11
   GO_BP:0031145   Anaphase-promoting complex-dependent catabolic process                                            21      8.10E--11
   GO_CC:0070062   Extracellular exosome                                                                             213     2.62E--20
   GO_CC:0005576   Extracellular region                                                                              129     1.88E--13
   GO_CC:0005615   Extracellular space                                                                               113     4.42E--13
   GO_CC:0005578   Proteinaceous ECM                                                                                 41      1.51E--12
   GO_CC:0031012   ECM                                                                                               43      2.31E--12
   GO_MF:0004298   Threonine-type endopeptidase activity                                                             11      4.09E--09
   GO_MF:0005201   ECM structural constituent                                                                        17      1.38E--08
   GO_MF:0005518   Collagen binding                                                                                  14      1.05E--06
   GO_MF:0004252   Serine-type endopeptidase activity                                                                28      1.18E--05
   GO_MF:0005515   Protein binding                                                                                   429     1.27E--05
  KEGG_PATHWAY                                                                                                               
   Hsa:04512       ECM--receptor interaction                                                                         23      1.23E--10
   Hsa:05146       Amebiasis                                                                                         25      2.11E--10
   Hsa:03050       Proteasome                                                                                        15      1.25E--08
   Hsa:04510       Focal adhesion                                                                                    30      2.76E--07
   Hsa:05222       Small cell lung cancer                                                                            16      1.52E--05

**Note:** Top five terms were selected according to *P*-value.

**Abbreviations:** DEGs, differentially expressed genes; HNSCC, head and neck squamous cell carcinoma; GO, gene ontology; BP, biological process; ECM, extracellular matrix; MHC, major histocompatibility; TAP, transporter associated with antigen processing; CC, cellular component; MF, molecular function.

###### 

The hub genes that had a degree \>22 in PPI network

  Gene       Regulation   Degree
  ---------- ------------ --------
  *CDK1*     Up           36
  *PTK2*     Up           34
  *ITGAV*    Up           29
  *APP*      Up           28
  *COL1A1*   Up           27
  *MMP9*     Up           27
  *AURKA*    Up           26
  *BMP2*     Up           26
  *ITGB4*    Up           26
  *CDC20*    Up           25
  *SDC4*     Up           25
  *COL1A2*   Up           23
  *ITGA6*    Up           23
  *PSMA7*    Up           23
  *STAT1*    Up           23

**Abbreviation:** PPI, protein--protein interaction.

###### 

Functional and pathway enrichment analysis of the DEGs in modules

  ID               Description                                                                                                        Count   *P*-value
  ---------------- ------------------------------------------------------------------------------------------------------------------ ------- -----------
  Module 1                                                                                                                                    
   GO_BP:0031145   Anaphase-promoting complex-dependent catabolic process                                                             17      1.73E--36
   GO_BP:0051436   Negative regulation of ubiquitin protein ligase activity involved in mitotic cell cycle                            16      4.09E--34
   GO_BP:0051437   Positive regulation of ubiquitin protein ligase activity involved in regulation of mitotic cell cycle transition   16      1.27E--33
   GO_BP:0006521   Regulation of cellular amino acid metabolic process                                                                14      2.99E--30
   GO_BP:0043161   Proteasome-mediated ubiquitin-dependent protein catabolic process                                                  16      8.04E--27
   GO_CC:0000502   Proteasome complex                                                                                                 12      5.82E--24
   GO_CC:0005839   Proteasome core complex                                                                                            8       2.77E--17
   GO_CC:0005829   Cytosol                                                                                                            19      4.58E--14
   GO_CC:0005654   Nucleoplasm                                                                                                        16      2.87E--10
   GO_CC:0005634   Nucleus                                                                                                            18      1.40E--08
   GO_MF:0004298   Threonine-type endopeptidase activity                                                                              8       2.90E--17
   GO_MF:0005515   Protein binding                                                                                                    18      1.49E--05
   Hsa:03050       Proteasome                                                                                                         12      2.16E--21
  Module 2                                                                                                                                    
   GO_BP:0030198   ECM organization                                                                                                   17      5.98E--29
   GO_BP:0030574   Collagen catabolic process                                                                                         12      7.33E--23
   GO_BP:0030199   Collagen fibril organization                                                                                       7       2.78E--12
   GO_BP:0071230   Cellular response to amino acid stimulus                                                                           7       9.11E--12
   GO_BP:0007155   Cell adhesion                                                                                                      9       1.70E--08
   GO_CC:0005788   Endoplasmic reticulum lumen                                                                                        15      1.42E--24
   GO_CC:0005581   Collagen trimer                                                                                                    11      5.76E--19
   GO_CC:0005576   Extracellular region                                                                                               15      1.27E--11
   GO_CC:0031012   ECM                                                                                                                9       2.85E--10
   GO_CC:0005578   Proteinaceous ECM                                                                                                  8       5.96E--09
   GO_MF:0005201   ECM structural constituent                                                                                         11      4.30E--20
   GO_MF:0048407   Platelet-derived growth factor binding                                                                             5       3.76E--10
   GO_MF:0038132   Neuregulin binding                                                                                                 3       1.20E--05
   Hsa:04512       ECM--receptor interaction                                                                                          15      5.56E--25
   Hsa:04974       Protein digestion and absorption                                                                                   13      4.91E--20
   Hsa:04510       Focal adhesion                                                                                                     15      1.76E--19
   Hsa:05146       Amebiasis                                                                                                          12      7.43E--17
   Hsa:04151       PI3K-Akt signaling pathway                                                                                         15      2.72E--16
   Hsa:05222       Small cell lung cancer                                                                                             7       3.22E--08

**Abbreviations:** DEGs, differentially expressed genes; GO, gene ontology; BP, biological process; MHC, major histocompatibility; TAP, transporter associated with antigen processing; CC, cellular component; ECM, extracellular matrix; MF, molecular function.
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